Biological Testing TRIZ Cases

Pyridinone compounds selectively inhibit DOCK1 GEF activity, blocking cancer cell invasion while sparing DOCK2 and DOCK5 to prevent immune system side effects.

Antigen-conjugated gold nanoparticles capture specific IgE complexes via anti-IgE antibodies on the test strip.

Segmenting the isolation process with preliminary and secondary markers resolves specificity complexity trade-offs for CNS-derived EVs.

Computes a specificity metric from target and control binding readouts to resolve throughput constraints in single-cell antibody discovery.

Dry analysis element uses a porous medium layer to store anti-analyte particles with high stability.

Post-mortem blood analysis isolates CD34+ and CD3+ cells to establish mixed chimerism, eliminating living donor risks.

Quantitating MDSC5 levels via flow cytometry resolves the lack of biological markers for early detection and prognosis in renal cell carcinoma.

Targeting MGAT5B enzyme activity resolves CA125 specificity issues, enabling accurate mucinous ovarian cancer diagnosis via non-invasive serum immunoassay.

A reaction unit separates incubation from bound-free cleaning to enable flexible disk rotation and stable temperature control.

Photoactivatable fluorescent labels transform upon light exposure, allowing accurate sorting of adherent cells without compromising cellular health.

A labeled glucose tracer system estimates fractional gluconeogenesis via mass spectrometry to determine patient metabolic state.

Segmented 10 to 50 μm biomaterial slices allow rapid assessment of tissue regeneration without extensive three-dimensional processing.

Magnetic extraction removes pathological hemoglobin S cells to prevent iron overload from transfusions.

Short interfering peptides bind interfering antibodies to eliminate false positives while maintaining assay sensitivity.

A 3D microtissue culture method screens drug efficacy by applying compounds at specific time points based on half-life and concentration parameters.

A chromatographic detection pad uses capillary flow to separate free hemoglobin from red blood cells.

A lateral flow assay device uses physical barriers to trap red blood cells from whole blood samples.

Immunity detecting kit uses PMA and LPS to stimulate immune cells for cytokine measurement.

A semi-sequential assay procedure uses immobilized capture reagents to bind analytes and detectable moieties for precise analysis.

Segmented test strips detect nicotine and glycerine to distinguish traditional cigarettes from e-cigarettes, resolving detection ambiguity.

Aliphatic chelating groups mediate lanthanide ion binding to eliminate heavy metal quenching errors.

Water and alcohol mixture extracts adenosine metabolites from dried blood spots, enabling early diagnosis of severe combined immunodeficiency.

Segmenting total and non-active isomer measurements via selective antibodies resolves the trade-off between assay speed and analytical accuracy.

A calibration method derives analyte concentration from current ratios measured in electrochemical reactors.